Preparation method of traditional Chinese medicine for treating hyperlipemia caused by deficiency of both yin and yang

Abstract

The invention relates to a preparation method of a traditional Chinese medicine for treating hyperlipemia caused by deficiency of both yin and yang, belonging to the technical field of preparation methods of traditional Chinese medicines. The existing method for treating hyperlipemia caused by deficiency of both yin and yang generally adopts lipid regulators, and has the defect of great toxic and side effects. The technical scheme is as follows: the preparation method comprises the following steps: taking Chinese date, Chinese yam, wheat, radix trichosanthis, cajan, radix psuedostellariae, Morinda officinalis, Arillus Longan, Bighead Atractylodes Rhizome, semen dolichoris album, Cordyceps, broomrape, actinolite, eucommia, fleece-flower root, flasem milkvetch seed, fructus psoraleae, caramel, fenugreek, walnut kernel, dried rehmannia, radix polygonati officinalis, white peony root, lily root, angelica, ganoderma lucidum, wolfberry fruit, carrageenin, Semen sesami nigrum, glossy privet fruit, radix asparagi, radix trichosanthis, silkie, dendrobe, Chinese holly leaf, licorice and the like; and soaking the traditional Chinese medicines in water, decocting with soft fire, and filtering to remove slag to obtain liquor, thereby obtaining the traditional Chinese medicine for treating hyperlipemia caused by deficiency of both yin and yang. The prepared traditional Chinese medicine has the advantages of small toxic and side effects, short treatment course and high cure rate.

Description

technical field [0001] The invention relates to the technical field of preparation methods of traditional Chinese medicines, in particular to a preparation method of traditional Chinese medicines for treating hyperlipidemia of yin and yang deficiency type. [0002] Background technique [0003] At present, in the treatment of hyperlipidemia of both yin and yang deficiency type, blood lipid-regulating drugs are generally used: [0004] 1. Fenofibrate: ①The incidence of adverse reactions is about 2%-15%. Gastrointestinal reactions and insomnia are more common. ②Contraindications: Patients allergic to this product, patients with history of gallbladder disease, patients with cholelithiasis, patients with severe renal insufficiency, hepatic insufficiency, primary biliary cirrhosis or persistent abnormal liver function of unknown cause. ③Use with caution in patients with gallstones, liver insufficiency, and renal insufficiency. ④ During the use of this product, if there is an...

AI Technical Summary

Problems solved by technology

[0008] 5. Fluvastatin: ① The adverse reaction is mild and short-lived dyspepsia

③ This product interferes with the diagnosis: a. Hemoglobin, hematocrit, and white blood cell count may decrease

④ Poor curative effect on homozygous familial hypercholesterolemia

Due to the complete lack of low-density lipoprotein (LDL) receptors in patients with homozygous familial hypercholesterolemia, simvastatin is less effective in these patients

Images